Rubicon Research P/B Ratio
Rubicon Research (RUBICON) P/B ratio is 19.46 (High), book value per share ₹758.24 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Rubicon Research share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
RUBICON P/B Ratio — Valuation Insights & Book Value Analysis
Rubicon Research price-to-book ratio interpretation, valuation status and historical context — current P/B 19.46 (High). View RUBICON price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 19.46, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 900.5% above historical average
- Trading at premium to sector average PB of -0.31
Rubicon Research P/B Ratio Historical Trend
RUBICON annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review Rubicon Research price earnings to evaluate earnings-based valuation against sector peers.
RUBICON Historical P/B Ratio — Book Value Per Share & Year-End Price
Rubicon Research annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.0 | ₹758.24 | ₹1520.20 | ₹1,289 | Moderate |
| 2025 | 1.89 | ₹360.67 | ₹680.75 | ₹541 | Moderate |
RUBICON vs Healthcare Peers — P/B Ratio Comparison
Rubicon Research P/B 19.46 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |